SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-288999
Filing Date
2014-07-31
Accepted
2014-07-31 13:33:51
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d736138d10q.htm 10-Q 906593
2 EX-23.1 d736138dex231.htm EX-23.1 2107
3 EX31.1 d736138dex311.htm EX-31.1 8348
4 EX-31.2 d736138dex312.htm EX-31.2 8431
5 EX-32.1 d736138dex321.htm EX-32.1 3433
  Complete submission text file 0001193125-14-288999.txt   8835020

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bmrn-20140630.xml EX-101.INS 1621686
7 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20140630.xsd EX-101.SCH 61053
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20140630_cal.xml EX-101.CAL 113554
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20140630_def.xml EX-101.DEF 441398
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20140630_lab.xml EX-101.LAB 537098
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20140630_pre.xml EX-101.PRE 515392
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 141005626
SIC: 2834 Pharmaceutical Preparations